ODI Pharma AB (ODI.ST) Research

Based in Stockholm, Sweden, ODI Pharma AB (publ) is a pharmaceutical enterprise that commenced operations in 2018. This company specializes in the manufacture and supply of both medicinal cannabis and cosmetic items throughout Europe. Its product line includes cannabidiol-enriched skincare solutions, such as facial creams, masks, and body balms, all sold under the Kandol. brand via its e-commerce site, kandol.net.

Market snapshot

Symbol
ODI.ST
Price
$2.68
Day change
-12.42%
Market cap
$49.1M
P/E ratio
-177.48x
52-week range
1-5.45
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • 2cureX AB (publ) (2CUREX.ST)
  • Aptahem AB (publ) (APTA.ST)
  • Episurf Medical AB (publ) (EPIS-B.ST)
  • Fluicell AB (publ) (FLUI.ST)
  • Gabather AB (publ) (GABA.ST)
  • Guard Therapeutics International AB (publ) (GUARD.ST)
  • Prostatype Genomics AB (publ) (PROGEN.ST)
  • Qlife Holding AB (publ) (QLIFE.ST)

Open ODI Pharma AB (ODI.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.